Call for Abstract

2nd International Conference on Cardiovascular Medicine and Cardiac Surgery , will be organized around the theme “Explore the possibilities towards better Cardiac Health”

Cardiovascular 2017 is comprised of 16 tracks and 88 sessions designed to offer comprehensive sessions that address current issues in Cardiovascular 2017.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Cardiovascular Medicine Conferences are the most comprehensive provider of cardiovascular services specializing in the prevention, detection, management and treatment of adult cardiovascular diseases. Cardiovascular Medicine Conferences is a platform for postgraduate education and scientific work in the fields of cardiologyangiology, hypertension and cardiac and vascular surgery.

  • Track 1-1Advances in cardiovasuclar medicine
  • Track 1-2Cardiovascular regenerative medicine
  • Track 1-3Cardiovascular revascularization medicine
  • Track 1-4Cardiovascular medicine clinical practice
  • Track 1-5Aspirin therapy
  • Track 1-6Beta-Blocker therapy
  • Track 1-7Antiarrhythmics
  • Track 1-8Traditional Chinese medicine

Cardiovascular Disease is a major cause of disability and premature death throughout the world. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, generally in middle age. Acute coronary events (heart attacks) and cerebrovascular events (strokes) frequently occur suddenly, and are often fatal before medical care can be given. Cardiology Conferences promotes awareness against Risk factor modification which reduces clinical events and premature death in people with established cardiovascular disease as well as in those who are at high cardiovascular risk due to one or more risk factors.

  • Track 2-1Myocardial infarction
  • Track 2-2Ischemic heart diseases
  • Track 2-3Rheumatic and valvular heart disease
  • Track 2-4Aorta diseases and marfan syndrome
  • Track 2-5Hypertention
  • Track 2-6Smoking and heart diseases
  • Track 2-7Coronery heart diseases
  • Track 2-8Congenital heart diseases

Cardiovascular nursing is a specialty that works with patients who suffer from numerous conditions of the cardiovascular system. Cardiovascular nurses facilitate treat conditions like unstable angina, myocardial infarction, cardiomyopathy, coronary artery disease, cardiac dysrhythmia and congestive heart failure under the direction of a heart specialist (cardiologist). Cardiovascular nurses perform postoperative care on a stress test evaluations, cardiac monitoring, surgical unit, health assessments and vascular monitoring. Cardiovascular nurses must have Advanced Cardiac Life Support and Basic Life Support certification. Cardiovascular nurses must possess specialized skills including defibrillation, electrocardiogram monitoring and medication administration by continuous intravenous drip. Cardiovascular nurses care for people with Cardiovascular disease and interact with their patients families. They may monitor and treat acutely ill patients, or they may focus on cardiovascular rehabilitation helping patients make lifestyle changes to prevent the worsening of their disease.

  • Track 3-1Cardiac intensive care nursing
  • Track 3-2Pediatric cardiovascular nursing
  • Track 3-3Cardiovascular nursing epidemiology
  • Track 3-4Cardiovascular nursing-inventions
  • Track 3-5Diagnosis tests & procedures of cardiovascular nursing
  • Track 3-6 Nurse practitioner education

In childhood a disorder which involves both the heart and lungs problems, called Paediatric Cardiopulmonary disease. Epicardial adipose tissue (EAT) is the visceral fat deposit around the heart and is commonly increased in obese subjects. EAT is related to Cardio Metabolic risk factors and non-alcoholic fatty liver disease (NAFLD) in adults, but this relationship is not well known in children. (MI) Myocardial infarction is rare in childhood and adolescence. Children usually have either an acute inflammatory condition of the coronary arteries diseases or an anomalous origin of the left coronary artery (LCA). Peripheral vascular diseases (PVDs) are circulation disorders that affect blood vessels outside of the heart and brain. In PVD, blood vessels are narrowed. Narrowing is usually caused by arteriosclerosis. We will be discussed more about the common problem of the baby heart as Cardiomyopathy, Myocarditis, Hypoplastic Left Heart Syndrome, Hypertension, Heart Murmur, Cardiac Arrest, Arrhythmogenic Right Ventricular Dysplasia, Cyanotic Heart Disease, and Paediatric Arrhythmia as well as more about Paediatric lungs disorders as Upper Airway Abnormalities, Child Interstitial Lung Disease (child), Chronic and Recurrent Respiratory Infections, Congenital Abnormalities and Paediatrics Chronic Obstructive Lung Diseases etc.

  • Track 4-1Pediatric hypertension
  • Track 4-2Pediatric arrhythmias
  • Track 4-3Pediatrics cystic fibrosis
  • Track 4-4Pediatrics chronic obstructive lung diseases
  • Track 4-5Pediatrics pulmonary diagnosis
  • Track 4-6Pediatric heart & lung cancer

Innovative advancements and researches are being made in cardiac surgery every day. The world's all advanced technology and most experienced cardiovascular surgeons and cardiologists are welcome here. Cardiovascular surgeries are those which performed on the heart and circulatory system including the major veins and arteries. Cardiovascular procedures performed by cardiac surgeons.
Our Conference Cardiovascular 2017 invites worlds all cardiovascular surgeons to grace their presence in this event and share their innovative ideas at this grand international scientific platform.

  • Track 5-1Coronary artery bypass graft surgery
  • Track 5-2Mitral valve repair or replacement
  • Track 5-3Tricuspid valve repair or replacement
  • Track 5-4Right anterior thoracic aortic valve repair or replacement
  • Track 5-5Aortic valve repair or replacement
  • Track 5-6Transaortic valve replacement (TAVR)
  • Track 5-7Endovascular aortic aneurysm repair (EVAR)
  • Track 5-8Ascending aorta surgery
  • Track 5-9Valve-sparing aortic root replacement
  • Track 5-10Ventricular septal defect repair
  • Track 5-11Atrial septal defect repair
  • Track 5-12Left ventricle assist device (LVAD)

Cardiovascular Toxicology deals with the adverse effects on the heart or blood systems which result from exposure to toxic chemicals. It describes safety data of detrimental effects of new cardiovascular drugs. Cardiac toxicity is damage to the heart by harmful chemicals. As part of your treatment, you may be given toxins (drugs) to kill cancer cells. A side effect is that the normal cells in and around your heart can also be killed.

  • Track 6-1Chemotherapy
  • Track 6-2Pericarditis
  • Track 6-3Targeted therapy
  • Track 6-4Symptoms of cardiac toxicity
  • Track 6-5Cardiac oncology

Cardiovascular pathology refers to the diseases of heart and vessels and represent the main cause of death in the world. The most important (as incidence and consequences) are atherosclerosis, ischemic heart disease (angina and miocardial infarct), brain infarct and hemorrhage. Cardiac Pathology is instrumental in diagnosing and planning treatment for the wide range of heart diseases and disorders seen at the Heart Institute. Cardiac Pathology is also an integral part of much Heart Institute research.

  • Track 7-1Coronary atherosclerosis
  • Track 7-2Acute myocardial infarction
  • Track 7-3Acute viral myocarditis
  • Track 7-4Ischemic fibrosis of myocardium
  • Track 7-5Rheumatic carditis

The use of alternative medical practices in the United States is growing day by day. The most commonly used approaches are herbs, supplements, and other pharmacological therapies, that are needed for patients care with focusing on potential effects, cardiovascular disease, treatment interactions and adverse effects. Potentially serious adverse effects and interactions with alternative cardiovascular medicine exist for many supplements and herbs. There are currently short mechanistic data and very limited data on the effect of alternative medical therapies on clinical outcomes. Clinical trials with satisfactory power to detect effects of cardiovascular alternative medicine therapies on safety and clinical outcomes are needed. Up to these data are available, clinicians must be aware of the increasing use of cardiovascular alternative medicine therapies approaches by their patients and the potential for interactions with evidence-based strategies and should focus on treatment with proven, conventional therapies.

  • Track 8-1Chelation therapy
  • Track 8-2Dietary treatments
  • Track 8-3Phytotherapy/herbal medicine
  • Track 8-4Aromatherapy
  • Track 8-5Mind-body therapies

Heart failure is a growing epidemic caused by cardiomyocyte depletion. Current therapies prolong survival by protecting remaining cardiomyocytes but are unable to overcome the fundamental problem of regenerating lost cardiomyocytes. Several strategies for promoting heart regeneration have emerged from decades of intensive study. Although some of these strategies remain confined to basic research, others are beginning to be tested in humans. We review strategies for cardiac regeneration and summarize progress of related clinical trials.

 

  • Track 9-1Cardiac tissue engineering
  • Track 9-2Cardiac cell therapies
  • Track 9-3Biomaterials for Blood Vessel Formation
  • Track 9-4Neocardiogenesis Research
  • Track 9-5Stem cell therapy of cardiac disease

Cardiovascular Biology is the biological mechanisms that control the functions of blood vessels and to translate this knowledge into treatments for cardiovascular and other diseases. The heart and vasculature are the first organs to function in the developing embryo. Without them, life cannot progress and our cardiovascular system is crucial for our health throughout life.

  • Track 10-1 Cardiac hypertrophy
  • Track 10-2Cardiovascular genetics
  • Track 10-3Cardiomyopathies

Cardiorenal syndrome (CRS) is an umbrella term used in the medical field that defines disorders of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. The heart and the kidneys are involved in maintaining hemodynamic stability and organ perfusion through an intricate network. These two organs communicate with one another through a variety of pathways in an interdependent relationship. Kidney failure is very common in patients suffering from congestive heart failure. It was shown that kidney failure complicates one-third of all admissions for heart failure, which is the leading cause of hospitalization in the United States among adults over 65 years old.

Cardiac devices are used to diagnose and treat heart disease and related health problems. Pacemakers and implantable defibrillators are devices that monitor and help control abnormal heart rhythms.

  • Track 12-1Ventricular assist device
  • Track 12-2Artificial cardiac pacemaker
  • Track 12-3Implantable cardioverter-defibrillator
  • Track 12-4Cardiac resynchronization Device
  • Track 12-5Artificial heart
  • Track 13-14S Trial
  • Track 13-2AFFIRM Trial
  • Track 13-3CAST Trial
  • Track 13-4COURAGE Trial
  • Track 13-5DIG Trial
  • Track 14-1Non-Invasive Cardiologist
  • Track 14-2Interventional Cardiologists
  • Track 14-3Electrophysiologists (EP)

We will examine recent variability and statistics regarding survival rates from cardiac arrest and industries related to Cardiovascular Medicine which will focus on challenging areas of research and it will assist us to steps ahead to improve the quality of care for cardiac problems like heart arrest etc. To meet the increasing demand for cardiovascular services and to ensure excellence in cardiac care delivery, on a series of upgrades and renovations that will enhance its ability to provide not only prompt also expert medical treatment, and even the best patient experience possible. This study will focus on the following topics: 3-D “Bioprinter, Information Technology, Thrombolytic [clot-busting] drug, Mobile Cardiovascular medicine apps, Social Media and Cardiovascular Medicine.

  • Track 15-1Cardiac ablation devices
  • Track 15-2Intra-aortic balloon pumps
  • Track 15-3Thrombolytic [clot-busting] drug
  • Track 15-43-D bioprinter
  • Track 15-5Mobile CVM apps
  • Track 15-6Social media and CV medicine

Our all Cardiology conferences has Case Studies act as informative examples to people who might also faces similar problems. Generally, Case Studies in Cardiovascular Medicine, should detail a particular medical case, reporting the background of the patient. They should discuss investigations undertaken in order to determine a diagnosis or differentiate between possible diagnoses, and should indicate the type of treatment the patient underwent as a result. In one piece we can conclude that Case Studies is an useful and informative part of every doctor or physician's medical education, which actually encourage us to include this session track on our international cardiovascular medicine conference which is going to be held at Manchester, UK.

  • Track 16-1Case studies in cardio-oncology
  • Track 16-2Case studies in myocardial infarction
  • Track 16-3Case studies in atherosclerosis
  • Track 16-4Management of cardiac disease in pregnancy
  • Track 16-5Right heart failure in carcinoid syndrome
  • Track 16-6Outcomes in diabetes